← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2016Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (21 distinct, 8 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT07153744CollaboratorPhase 4Sep 1, 2025
- NCT06462313CollaboratorN/AJul 22, 2024
- NCT05794425CollaboratorPhase 1/Phase 2Aug 1, 2023
- NCT05901779CollaboratorN/AApr 1, 2023
- NCT05159947CollaboratorPhase 3Dec 31, 2021
- NCT04901117CollaboratorPhase 4Jun 30, 2021
- NCT04400695Overall official - principal investigatorPhase 3Jul 31, 2020
- NCT02985372CollaboratorPhase 3Dec 1, 2016
Details
- Last known activity
- Sep 1, 2025